1. In this issue

   News 02 November 2017 Pages: 563 - 564

2. Malignant mesenchymal neoplasms of the dermis and subcutis mimicking benign lesions: a case-based review

   • Thomas Mentzel
   • Thomas Brenn

   Original Article 12 July 2017 Pages: 565 - 574

   

3. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression

   • Kathleen Lambein
   • Mieke Van Bockstal
   • Louis Libbrecht

   Original Article 31 May 2017 Pages: 575 - 587

   

4. Characterization of HER2 gene amplification heterogeneity in invasive and in situ breast cancer using bright-field in situ hybridization

   • António Polónia
   • Guilherme Oliveira
   • Fernando Schmitt

   Original Article 13 July 2017 Pages: 589 - 598

   

5. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1^neg/CK7^pos/HepPar-1^pos immunophenotype

   • Abbas Agaimy
   • Florian Fuchs
   • Florian Haller

   Original Article 30 May 2017 Pages: 599 - 609

   

6. Small bowel adenocarcinoma complicating Crohn’s disease: a single-centre experience emphasizing the importance of screening for dysplasia

   • Chloé Grolleau
   • Nicolas M. Pote
   • Dominique L. Cazals-Hatem

   Original Article 18 April 2017 Pages: 611 - 617

   

7. Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series

   • Claudio De Vito
   • Debashis Sarker
   • Alberto Quaglia

   Original Article 13 July 2017 Pages: 619 - 629

   

8. Desmoplastic small round cell tumor: evaluation of reverse transcription-polymerase chain reaction and fluorescence in situ hybridization as ancillary molecular diagnostic techniques

   • Mustafa Mohamed
   • David Gonzalez
   • Khin Thway

   Original Article 26 July 2017 Pages: 631 - 640

   

9. Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting

   • Ekkehard Hewer
   • Nadine Prebil
   • Erik Vassella

   Original Article 19 August 2017 Pages: 641 - 649

   

10. MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome

    • Francesca Galuppini
    • Loris Bertazza
    • Gianmaria Pennelli

    Original Article 31 August 2017 Pages: 651 - 658

    

11. Clinicopathological analysis in PTCL-NOS with CADM1 expression

    • Takeharu Kato
    • Hiroaki Miyoshi
    • Koichi Ohshima

    Original Article 22 September 2017 Pages: 659 - 666

    

12. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center

    • Diana Bell
    • Adel K. El-Naggar
    • Paul W. Gidley

    Brief Report 26 May 2017 Pages: 667 - 672

    

13. A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component

    • Hussein Nassereddine
    • Nicolas Poté
    • Anne Couvelard

    Brief Report 26 June 2017 Pages: 673 - 678

    

14. Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency

    • Mukul Vij
    • Naresh P. Shanmugam
    • Mohamed Rela

    Brief Report 21 July 2017 Pages: 679 - 683

    

15. About MET expression and other biomarkers in non-small cell lung cancer

    • Laetitia Lambros
    • Isabelle Quintin-Roué
    • Arnaud Uguen

    Letter to the Editor 31 August 2017 Pages: 685 - 686

16. Response to the letter to the editor of Lambros et al.

    • William Sterlacci
    • Alexandar Tzankov
    • Spasenija Savic

    Letter to the Editor 07 September 2017 Pages: 687 - 688